Live Breaking News & Updates on Immunotherapy

Stay informed with the latest breaking news from Immunotherapy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Immunotherapy and stay connected to the pulse of your community

FRESCO-2: Fruquintinib in Patients with Refractory Metastatic CRC

Arvind N. Dasari, MD, MS, provides a comprehensive overview of the FRESCO-2 trial investigating fruquintinib in patients with refractory metastatic colorectal cancer.

Adverse-event-management , Colorectal-cancer , Optimizing-treatment-approaches , Refractory-metastatic , Crc , Colorectal-cancer-treatment , Crc-treatment , Fresco-2 , Fruquintinib , Refractory-colorectal-cancer , Refractory-crc

Role of ADCs in HER2-Mutated NSCLC

The panel discusses the role of antibody-drug conjugates (ADCs) and the treatment of patients with HER2 non–small cell lung cancer.

Evolving-treatment-landscape , Non-small-cell-lung-cancer , Nsclc , Her2-nsclc , Her2-non-small-cell-lung-cancer , Her2-mutated-nsclc , Adc , Antibody-drug-conjugates , Treatment-guidelines , Trastuzumab-deruxtecan , Her2

Immunotherapy for Renal-Cell Carcinoma Saves Lives

A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.

United-kingdom , Boston , Massachusetts , United-states , Dana-farber-cancer-institute , Tonik-choueiri , European-medicines-agency , Harvard-medical-school , New-england-journal , Merck-sharp , Malignant-kidney-neoplasm-renal-cell-cancer-rcc-carcinoma-of-the

Uveal Melanoma Immunogenomic Score Shows Predictive Potential

Investigators examined 100 metastases and developed a Uveal Melanoma Immunogenomic Score to predict which patients will respond to immunotherapy.

Pennsylvania , United-states , Udai-kammula , Nature-communications , National-cancer-institute , University-of-pittsburgh-medical-center , University-of-pittsburgh , Hillman-cancer-center , Solid-tumor-cell-therapy-program , Uveal-melanoma-immunogenomic-score , Cancer-center , Pittsburgh-medical-center

The Immunotherapy Revolution for Autoimmune Diseases

Wynne Parry - Autoimmune diseases are a conundrum: Sometimes instead of protecting the body, the immune system turns against it. The target of its wrath varies depending on the...

Wynne-parry , The , Immunotherapy , Revolution , For , Autoimmune , Diseases ,

Engineered peptides show promise in cancer immunotherapy

In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.

Texas , United-states , Wen-jiang , Betty-kim , University-of-texas-md-anderson-cancer-center , National-cancer-institute , Us-department-of-defense , Anderson-cancer , Nature-biomedical-engineering , Cancer-center , Immunotherapy , Reast-cancer

Has Immunotherapy Found Its Place in Pancreatic Cancer?

A new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients with borderline resectable pancreatic cancer.

United-states , North-carolina , American , Zeva-wainberg , American-association-for-cancer-research , Duke-university-in-durham , University-of-california-los-angeles , California-los-angeles , American-association , Cancer-research , Annual-meeting

FOX and Friends

constipation, dizziness or fainting, changes in appetite, thirst, or urine, confusion, memory problems, muscle pain or weakness, fever, rash, itching, or flushing. there may be other side effects. tell your doctor about all your medical conditions, including immune system problems, if you've had or plan to have an organ or stem cell transplant, received chest radiation or have a nervous system problem. keytruda is an immunotherapy and is also being studied in hundreds of clinical trials exploring ways to treat even more types of cancer. it's tru. keytruda from merck. see all the types of cancer keytruda is known for at keytruda.com and ask your doctor if keytruda could be right for you. hi, i'm kim, and i lost 67 pounds on golo. when i was diagnosed with breast cancer, food became my comfort. i didn't think i looked pretty anymore, so i let myself go. i've seen the golo commercials for a while. what stuck out to me most was there was no celebrity endorser.

Doctor , Side-effects , Conditions , Memory-problems , Muscle-pain , Weakness , Appetite , Constipation , Itching , Fever , Urine , Confusion

Trump Hush Money Trial

because they go first and so they're going to anticipate what the defense is going to say an opening and they're going to want to take the sting out of any of the arguments that lhs talked about. >> very interesting with opening statements in donald trump's first criminal trial, just minutes away, we're going to get, uh, judge's perspective. from someone who's known the judge presiding over this case more than a decade. that's ahead the sinking of the titanic. >> how would really happen? >> special too well with premier sunday at nine on cnn, if advanced lung cancer has you searching for possibilities, discover a different first treatment immunotherapies work with your immune system to attack cancer, but up devo plus your voice is the first combination of two immunotherapy these for adults newly diagnosed with non-small cell lung cancer that has spread tests positive for pd-l1 and does not have an abnormal egfr or alk gene up devo plus

Donald-j-trump , Trump-hush-money-trial , Defense , Opening , Arguments , Any , Statements , Sting , Lhs , Judge , Depths-paperwork-case , Someone

New Cancer Immunotherapy Balances Efficacy and Safety

The new immunotherapy employing cytokine proteins offers a promising treatment avenue, targeting tumors while preserving healthy cells from damage.

Virginia , United-states , Virginia-tech-college-of-engineering , Virginia-tech , Key-factor , Preventing-systemic-toxicity , Rong-tong , Immunotherapy , Ancer , Ytokines ,